Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Alberti

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Sarcoma|May 3, 2012
Desmoplastic small round cell tumor: current management and recent findingsArmelle Dufresne, Philippe Cassier, Laure Couraud, et al.
Expert Opinion on Emerging Drugs|March 16, 2007
Emerging drugs for the treatment of soft tissue sarcomasPhilippe A Cassier, Armelle Dufresne, Jérôme Fayette, et al.
International Journal of Cancer|October 16, 2010
Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide responseAngélique Gougelet, Daniel Pissaloux, Anthony Besse, et al.
Cancer Science|February 25, 2015
Prediction of desmoid tumor progression using miRNA expression profilingArmelle Dufresne, Marie Paturel, Laurent Alberti, et al.
Cancer Management and Research|February 2, 2018
Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patientsStefania Benini, Gabriella Gamberi, Stefania Cocchi, et al.
Virchows Archiv : an International Journal of Pathology|February 22, 2018
Unclassified sclerosing malignant melanomas with AKAP9-BRAF gene fusion: a report of two cases and review of BRAF fusions in melanocytic tumorsEmilie Perron, Daniel Pissaloux, Angela Neub, et al.
The American Journal of Surgical Pathology|April 11, 2018
Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR): Report of 4 Cases of a Nevus Variant With Potential Diagnostic ChallengeEmilie Perron, Daniel Pissaloux, Celine Charon Barra, et al.
Sarcoma|March 26, 2011
miRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of SarcomasAngélique Gougelet, Jennifer Perez, Daniel Pissaloux, et al.
Plos One|April 18, 2013
Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samplesJean-Baptiste Bachet, Séverine Tabone-Eglinger, Sophie Dessaux, et al.
BMC Cancer|October 27, 2015
KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcomeMehdi Brahmi, Laurent Alberti, Armelle Dufresne, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Sarcoma|May 3, 2012
Desmoplastic small round cell tumor: current management and recent findingsArmelle Dufresne, Philippe Cassier, Laure Couraud, et al.
Expert Opinion on Emerging Drugs|March 16, 2007
Emerging drugs for the treatment of soft tissue sarcomasPhilippe A Cassier, Armelle Dufresne, Jérôme Fayette, et al.
International Journal of Cancer|October 16, 2010
Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide responseAngélique Gougelet, Daniel Pissaloux, Anthony Besse, et al.
Cancer Science|February 25, 2015
Prediction of desmoid tumor progression using miRNA expression profilingArmelle Dufresne, Marie Paturel, Laurent Alberti, et al.
Cancer Management and Research|February 2, 2018
Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patientsStefania Benini, Gabriella Gamberi, Stefania Cocchi, et al.
Virchows Archiv : an International Journal of Pathology|February 22, 2018
Unclassified sclerosing malignant melanomas with AKAP9-BRAF gene fusion: a report of two cases and review of BRAF fusions in melanocytic tumorsEmilie Perron, Daniel Pissaloux, Angela Neub, et al.
The American Journal of Surgical Pathology|April 11, 2018
Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR): Report of 4 Cases of a Nevus Variant With Potential Diagnostic ChallengeEmilie Perron, Daniel Pissaloux, Celine Charon Barra, et al.
Sarcoma|March 26, 2011
miRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of SarcomasAngélique Gougelet, Jennifer Perez, Daniel Pissaloux, et al.
Plos One|April 18, 2013
Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samplesJean-Baptiste Bachet, Séverine Tabone-Eglinger, Sophie Dessaux, et al.
BMC Cancer|October 27, 2015
KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcomeMehdi Brahmi, Laurent Alberti, Armelle Dufresne, et al.
Pageof 5